Inovio Hit With Shareholder Derivative Suit Over Coronavirus Vaccine Claims

(June 17, 2020, 9:11 AM EDT) -- PHILADELPHIA — Two biopharmaceutical company investors filed a shareholder derivative lawsuit against the company’s board of directors on June 15 in Pennsylvania federal court, alleging that the defendants breached their fiduciary duty and violated provisions of federal securities law by misrepresenting that the company had developed a vaccine for the novel coronavirus (Krishna Kishor Devarakonda, et al. v. J. Joseph Kim, et al., No. 20-2829, E.D. Pa.)....

Attached Documents

Related Sections